Mankind Pharma Limited

NSE MANKIND.NS

Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -249.57 M

Mankind Pharma Limited Net Cash Used For Investing Activities is USD -249.57 M for the year ending March 31, 2024, a -92.26% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -129.81 M, a 28.01% change year over year.
  • Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -180.32 M, a -8.03% change year over year.
  • Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -166.92 M, a -186.43% change year over year.
  • Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -58.28 M, a 8.86% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
SV Wall Street
NSE: MANKIND.NS

Mankind Pharma Limited

CEO Mr. Sheetal Arora
IPO Date May 9, 2023
Location India
Headquarters 262, Okhla Industrial Estate
Employees 19,540
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care
Description

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

StockViz Staff

February 8, 2025

Any question? Send us an email